Increasing Endocannabinoid Tone Alters Anxiety-Like and Stress Coping Behaviour in Female Rats Prenatally Exposed to Valproic Acid
- PMID: 34207178
- PMCID: PMC8233839
- DOI: 10.3390/molecules26123720
Increasing Endocannabinoid Tone Alters Anxiety-Like and Stress Coping Behaviour in Female Rats Prenatally Exposed to Valproic Acid
Abstract
Given the sex differences evident in the prevalence of autism, there is an increased awareness of the importance of including females in autism research to determine sexual dimorphism and sex-specific treatments. Cannabinoids and endocannabinoid modulators have been proposed as potential novel treatments for autism-related symptoms; however, few studies to date have examined if these pharmacological agents elicit sex-specific effects. The aim of the present study was to use the valproic acid (VPA) model of autism to compare the behavioural responses of male and female rats and examine the effects of increasing endocannabinoid tone on the behavioural responses of VPA-exposed female rats. These data revealed that VPA-exposed male, but not female, rats exhibit reduced social responding in the three-chamber and olfactory habituation/dishabituation (OHD) test during adolescence. In comparison, VPA-exposed female, but not male, adolescent rats exhibited anxiety-like behaviour in the elevated plus maze (EPM) and open field test (OFT). In VPA-exposed female rats, increasing 2-AG levels augmented anxiety-like behaviour in the EPM and OFT, while increasing AEA levels reduced stress coping behaviour in the swim stress test. These data highlight sexual dimorphic behaviours in the VPA model and indicate that enhancing endocannabinoid levels may exacerbate negative affective behaviour in VPA-exposed females. Thus, considerations should be paid to the possible sex-specific effects of cannabinoids for the treatment of symptoms associated with autism.
Keywords: 2-AG; FAAH; MGL; VPA; anandamide; autism; sex differences; social behaviour.
Conflict of interest statement
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Figures





Similar articles
-
Pharmacological inhibition of fatty acid amide hydrolase attenuates social behavioural deficits in male rats prenatally exposed to valproic acid.Pharmacol Res. 2016 Nov;113(Pt A):228-235. doi: 10.1016/j.phrs.2016.08.033. Epub 2016 Aug 31. Pharmacol Res. 2016. PMID: 27592249
-
Sex-specific autistic endophenotypes induced by prenatal exposure to valproic acid involve anandamide signalling.Br J Pharmacol. 2018 Sep;175(18):3699-3712. doi: 10.1111/bph.14435. Epub 2018 Aug 9. Br J Pharmacol. 2018. PMID: 29968249 Free PMC article.
-
Alterations in the endocannabinoid system in the rat valproic acid model of autism.Behav Brain Res. 2013 Jul 15;249:124-32. doi: 10.1016/j.bbr.2013.04.043. Epub 2013 May 1. Behav Brain Res. 2013. PMID: 23643692
-
In utero exposure to valproic acid and autism--a current review of clinical and animal studies.Neurotoxicol Teratol. 2013 Mar-Apr;36:47-56. doi: 10.1016/j.ntt.2013.01.004. Epub 2013 Feb 8. Neurotoxicol Teratol. 2013. PMID: 23395807 Review.
-
A Systematic Review of the Valproic-Acid-Induced Rodent Model of Autism.Dev Neurosci. 2020;42(1):12-48. doi: 10.1159/000509109. Epub 2020 Aug 18. Dev Neurosci. 2020. PMID: 32810856
Cited by
-
Pathophysiological Studies of Monoaminergic Neurotransmission Systems in Valproic Acid-Induced Model of Autism Spectrum Disorder.Biomedicines. 2022 Feb 27;10(3):560. doi: 10.3390/biomedicines10030560. Biomedicines. 2022. PMID: 35327362 Free PMC article. Review.
-
Individually tailored dosage regimen of full-spectrum Cannabis extracts for autistic core and comorbid symptoms: a real-life report of multi-symptomatic benefits.Front Psychiatry. 2023 Aug 21;14:1210155. doi: 10.3389/fpsyt.2023.1210155. eCollection 2023. Front Psychiatry. 2023. PMID: 37671290 Free PMC article.
-
Alterations of the endocannabinoid system in autism spectrum disorder: a systematic review and meta-analysis.Eur Arch Psychiatry Clin Neurosci. 2025 Jun 15. doi: 10.1007/s00406-025-02031-x. Online ahead of print. Eur Arch Psychiatry Clin Neurosci. 2025. PMID: 40518463
References
-
- American Psychiatric Assocation . Diagnostic and Statistical Manual of Mental Disorders. 5th ed. American Psychiatric Publishing; Arlington, VA, USA: 2013.
-
- Simonoff E., Pickles A., Charman T., Chandler S., Loucas T., Baird G. Psychiatric disorders in children with autism spectrum disorders: Prevalence, comorbidity, and associated factors in a population-derived sample. J. Am. Acad. Child Adolesc. Psychiatry. 2008;47:921–929. doi: 10.1097/CHI.0b013e318179964f. - DOI - PubMed
-
- Maenner M.J., Shaw K.A., Baio J., Patrick M., DiRienzo M., Christensen D.L., Wiggins L.D., Pettygrove S., Daniels J., Warren Z., et al. Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years-Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2016. MMWR Surveill. Summ. 2020;69:1–12. doi: 10.15585/mmwr.ss6904a1. - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical